These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 14647960

  • 1. Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects.
    Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH.
    Psychopharmacology (Berl); 2004 May; 173(3-4):383-90. PubMed ID: 14647960
    [Abstract] [Full Text] [Related]

  • 2. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
    Curran HV, Verheyden SL.
    Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
    [Abstract] [Full Text] [Related]

  • 3. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 4. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
    Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E.
    Psychopharmacology (Berl); 2005 Aug; 180(4):607-11. PubMed ID: 15372137
    [Abstract] [Full Text] [Related]

  • 5. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 6. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S, Powell JH.
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [Abstract] [Full Text] [Related]

  • 7. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 8. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [Abstract] [Full Text] [Related]

  • 9. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

  • 10. Chronic MDMA (ecstasy) use, cognition and mood.
    McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C.
    Psychopharmacology (Berl); 2004 May; 173(3-4):434-9. PubMed ID: 15088077
    [Abstract] [Full Text] [Related]

  • 11. Hippocampal 1H-MRSI in ecstasy users.
    Obergriesser T, Ende G, Braus DF, Henn FA.
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):114-6. PubMed ID: 11697571
    [Abstract] [Full Text] [Related]

  • 12. Neuroimaging research in human MDMA users: a review.
    Cowan RL.
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [Abstract] [Full Text] [Related]

  • 13. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
    Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O.
    J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
    [Abstract] [Full Text] [Related]

  • 14. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.
    McCann UD, Mertl M, Eligulashvili V, Ricaurte GA.
    Psychopharmacology (Berl); 1999 Apr; 143(4):417-25. PubMed ID: 10367560
    [Abstract] [Full Text] [Related]

  • 15. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B.
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [Abstract] [Full Text] [Related]

  • 16. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
    Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG.
    Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
    [Abstract] [Full Text] [Related]

  • 17. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M.
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [Abstract] [Full Text] [Related]

  • 18. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
    Watkins TJ, Raj V, Lee J, Dietrich MS, Cao A, Blackford JU, Salomon RM, Park S, Benningfield MM, Di Iorio CR, Cowan RL.
    Psychopharmacology (Berl); 2013 May; 227(1):41-54. PubMed ID: 23241648
    [Abstract] [Full Text] [Related]

  • 19. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report.
    Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ.
    Biol Psychiatry; 2001 Oct 01; 50(7):550-4. PubMed ID: 11600108
    [Abstract] [Full Text] [Related]

  • 20. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W.
    Lancet; 2001 Dec 01; 358(9296):1864-9. PubMed ID: 11741626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.